Cope with AIDS can be, if you select from the blood cells of the immune system, teach them to recognize and destroy the virus, and then introduce them back into the body.

American scientists told about the first successes in testing a new method of treatment for HIV / AIDS. During the first phase of clinical trials, they received convincing evidence of the safety of this approach. The development of the methodology is conducted by the American company VIRxSYS. T-lymphocytes from the patient's blood in the laboratory are treated with VRX496, which includes artificially synthesized parts of the virus that are not able to reproduce in the body. After the introduction of lymphocytes into the body, they begin to fight infection.

At this stage of the tests, the developers are faced with the task of proving its safety in order to move to more extensive experiments. The first patient received treatment last summer, since then two more have passed. There were no side effects associated with VRX496 in these three patients, "said Boro Drupulic, the company's research supervisor.

In view of the available data on the safety of the treatment, the researchers were allowed to immediately connect to the work of two more volunteers, although it was initially assumed that they would receive treatment only after the previous patient successfully passed. For work, people were selected who were not helped by at least two three-component antiviral therapy regimens. As planned, the first phase of the trials will require the participation of five people. After its completion and analysis of the results, scientists will start the second phase, where they will be able to establish the effectiveness of treatment of medicus. En.

Keywords:.